<i>Background:</i> Although ongoing cohort studies offer a unique opportunity to apply existing information collected prospectively to further the scientific understanding of Parkinson’s disease (PD), they typically have limited information for clinical diagnosis. <i>Methods:</i> We used combinations of self-report, International Classification of Diseases – 9th edition codes and antiparkinsonian medications to identify PD in the Cardiovascular Health Study. To determine whether the expected inverse association between smoking and PD is evident using our outcome definitions, we assessed baseline smoking characteristics for various definitions of PD. <i>Results:</i> We identified 60 cases with prevalent PD (1.0%; 95% confidence interval, CI = 0.8–1.3%) and 154 with incident PD by year 14. Clear associations were observed for current smokers (odds ratio, OR = 0.50; 95% CI = 0.26–0.95) and for those who smoked ≧50 pack-years (OR = 0.53; 95% CI = 0.29–0.96). Estimates for smoking were similar when ≧2 data sources were required. Estimates for self-report alone were attenuated towards null. <i>Conclusions:</i> Using multiple data sources to identify PD represents an alternative method of outcome identification in a cohort that would otherwise not be possible for PD research. Ongoing cohort studies can provide settings in which rapid replication and explorations of new hypotheses for PD are possible.